title: Multiple pathways regulating the anti-apoptotic protein clusterin in breast cancer.
abstract: Cancer chemotherapy inhibits tumor growth, in part, by triggering apoptosis, and anti-apoptotic proteins reduce the effectiveness of chemotherapy. Clusterin, a chaperone-like protein that binds to apoptotic and DNA repair proteins, is induced by chemotherapy and promotes tumor cell survival. Histone deacetylase inhibitors (HDIs) such as sodium butyrate and suberoylanilide hydroxamic acid (SAHA) are pharmacological agents that induce differentiation and apoptosis in cancer cells by altering chromatin structure, and we have found that combinations of chemotherapeutic drugs such as doxorubicin and HDIs efficiently induce apoptosis, even though they paradoxically induce high levels of clusterin. The hyper-expressed form of clusterin localizes to mitochondria, inhibits cytochrome c release, and is inhibited by the proteasome. When HDIs are used as single agents, clusterin suppresses cytochrome c release and apoptosis. However, doxorubicin/HDI-induced apoptosis is not inhibited by clusterin, and clusterin-resistant apoptosis corresponds with markers of the extrinsic/receptor-mediated apoptotic pathway. Thus, chemotherapy-HDI combinations are capable of overcoming an innate anti-apoptotic pathway of tumor cells, suggesting that chemotherapy-HDI combinations have potential for treating advanced stage breast cancer.
authors: Department of Molecular and Biomedical Pharmacology, Markey Cancer Center, University of Kentucky, MS-305 UKMC, Lexington, KY 40536, USA.
authors: Melissa K
authors: MK
authors: Ranney
authors: Ikhlas S A
authors: IS
authors: Ahmed
authors: Kelly R
authors: KR
authors: Potts
authors: Rolf J
authors: RJ
authors: Craven
mesh_terms: D051017:Apoptosis Regulatory Proteins / Q000502:physiology; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology; D051152:Clusterin / Q000235:genetics* / Q000378:metabolism; D045304:Cytochromes c / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D015972:Gene Expression Regulation, Neoplastic; D056572:Histone Deacetylase Inhibitors; D006801:Humans; D008928:Mitochondria / Q000378:metabolism; D008954:Models, Biological; D011499:Protein Processing, Post-Translational / Q000187:drug effects; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology*; D014407:Tumor Cells, Cultured
chemical_list: D051017:Apoptosis Regulatory Proteins; C495242:CLU protein, human; D051152:Clusterin; D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors; D045304:Cytochromes c
references: J Biol Chem. 1999 Mar 12;274(11):6875-81
references: 10066740
references: Oncogene. 2006 Aug 10;25(35):4890-903
references: 16568090
references: Nat Med. 2005 Jan;11(1):71-6
references: 15619634
references: Cancer. 2005 Jan 15;103(2):277-83
references: 15578711
references: Drug Discov Today. 2005 Feb 1;10(3):197-204
references: 15708534
references: Cancer Res. 2000 May 1;60(9):2547-54
references: 10811138
references: Proc Natl Acad Sci U S A. 2000 May 23;97(11):5907-12
references: 10823943
references: Am J Pathol. 2000 Aug;157(2):393-9
references: 10934144
references: J Endocrinol. 2001 Apr;169(1):97-110
references: 11250651
references: Science. 2001 Apr 27;292(5517):727-30
references: 11326099
references: Neoplasia. 2001 Jul-Aug;3(4):360-7
references: 11571636
references: Cell. 1975 Jul;5(3):319-22
references: 1056809
references: In Vitro. 1978 Nov;14(11):911-5
references: 730202
references: Breast Cancer Res Treat. 1984;4(4):269-74
references: 6518293
references: Surg Oncol. 1992 Aug;1(4):309-14
references: 1341265
references: J Biol Chem. 1995 Apr 7;270(14):7795-8
references: 7536190
references: Cell. 1995 May 19;81(4):505-12
references: 7538907
references: Biochemistry. 1996 May 14;35(19):6157-63
references: 8634259
references: Cell. 1996 Nov 1;87(3):565-76
references: 8898208
references: EMBO J. 1996 Nov 15;15(22):6189-96
references: 8947041
references: Biochemistry. 1997 Dec 9;36(49):15233-43
references: 9398251
references: Nat Rev Cancer. 2005 Apr;5(4):297-309
references: 15803156
references: Cancer Res. 2005 May 1;65(9):3815-22
references: 15867379
references: J Cell Physiol. 2005 Aug;204(2):463-9
references: 15685647
references: Biochem Pharmacol. 2005 Aug 1;70(3):394-406
references: 15950952
references: Cancer Res. 2005 Aug 1;65(15):6957-66
references: 16061681
references: Nat Cell Biol. 2005 Sep;7(9):909-15
references: 16113678
references: J Cell Biochem. 2005 Oct 1;96(2):293-304
references: 16088937
references: DNA Repair (Amst). 2005 Nov 21;4(11):1215-26
references: 15979949
references: Mol Pharmacol. 2005 Dec;68(6):1747-56
references: 16150928
references: Methods Enzymol. 2005;399:585-609
references: 16338383
references: Mol Cancer Ther. 2005 Dec;4(12):1837-49
references: 16373699
references: Mol Cancer Ther. 2005 Dec;4(12):1993-2000
references: 16373714
references: DNA Cell Biol. 2006 Jan;25(1):49-62
references: 16405400
references: Carcinogenesis. 2006 Feb;27(2):344-9
references: 16267097
references: Oncogene. 2006 Feb 23;25(8):1242-50
references: 16247463
references: Dev Cell. 2006 May;10(5):549-61
references: 16678772
references: Nutr Clin Pract. 2006 Aug;21(4):351-66
references: 16870803
references: Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10403-8
references: 10468620
references: J Biol Chem. 2001 Nov 30;276(48):44641-6
references: 11572859
references: J Biol Chem. 2001 Dec 14;276(50):47257-65
references: 11571297
references: Br J Pharmacol. 2002 Jan;135(1):79-86
references: 11786482
references: Int J Biochem Cell Biol. 2002 Nov;34(11):1430-48
references: 12200037
references: Mod Pathol. 2002 Nov;15(11):1221-6
references: 12429802
references: Oncol Rep. 2003 Mar-Apr;10(2):469-73
references: 12579291
references: J Biol Chem. 2003 Mar 28;278(13):11590-600
references: 12551933
references: J Cell Sci. 2003 Aug 1;116(Pt 15):3109-21
references: 12799419
references: J Nutr. 2003 Jul;133(7 Suppl):2485S-2493S
references: 12840228
references: Cell Death Differ. 2003 Aug;10(8):914-27
references: 12867999
references: Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9530-5
references: 12886021
references: J Cell Biochem. 2003 Oct 15;90(3):534-47
references: 14523988
references: Cancer Res. 2003 Nov 1;63(21):7291-300
references: 14612526
references: Curr Opin Cell Biol. 2003 Dec;15(6):725-31
references: 14644197
references: J Hepatol. 2004 Feb;40(2):278-84
references: 14739099
references: Cancer Res. 2004 Mar 1;64(5):1834-42
references: 14996747
references: Mol Cancer Ther. 2004 Mar;3(3):223-32
references: 15026542
references: Oncogene. 2004 Apr 12;23(16):2934-49
references: 15077155
references: J Cell Biochem. 2004 May 15;92(2):223-37
references: 15108350
references: Ann Med. 2004;36(4):285-95
references: 15224655
references: Exp Cell Res. 2004 Aug 15;298(2):560-73
references: 15265702
references: Oncogene. 2004 Aug 19;23(37):6304-15
references: 15318170
references: Cancer Res. 2004 Sep 1;64(17):6174-82
references: 15342402